Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Young-Hoon Jeong

Showing results (1-10 of 269) with videos related to

Pageof 27
Sort By:
Current Cardiology Reports|March 27, 2014
"East asian paradox": challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndromeYoung-Hoon Jeong
The New England Journal of Medicine|October 4, 2013
Clopidogrel with aspirin in minor stroke or transient ischemic attackYoung-Hoon Jeong
Korean Circulation Journal|April 7, 2022
Unguided De-Escalation Strategy From Potent P2Y<sub>12</sub> Inhibitors in Patients Presented With ACS: When, Whom and How?Jin Sup Park, Young-Hoon Jeong
JACC. Asia|January 9, 2023
Thrombosis and Anticoagulation in East Asian Patients With COVID-19: Another Phenotype of "East Asian Paradox"You-Jeong Ki, Young-Hoon Jeong
Journal of the American Heart Association|May 28, 2015
Platelet function tests: why they fail to guide personalized antithrombotic medicationDiana A Gorog, Young-Hoon Jeong
Thrombosis and Haemostasis|March 31, 2025
Factor XI Measurement in Acute Coronary SyndromeDiana A Gorog, Young-Hoon Jeong
Korean Circulation Journal|December 19, 2023
Type 2 Myocardial Infarction: Another Hidden Cause of Mortality During the COVID-19 PandemicEun Jeong Cho, Kyeongmin Byeon, Young-Hoon Jeong
JACC. Asia|November 6, 2025
Ethnicity, P2Y<sub>12</sub> Inhibitor Potency, and Bleeding: Revisiting the "East Asian Paradox"Phil Iver Guevarra, Udaya Tantry, Young-Hoon Jeong
JAMA|March 2, 2021
Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous InterventionHyun Kuk Kim, Jacek Kubica, Young-Hoon Jeong
JAMA|June 23, 2011
Standard- vs high-dose clopidogrel after percutaneous coronary interventionYoung-Hoon Jeong, Yongwhi Park, In-Suk Kim
Pageof 27

Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
Current Cardiology Reports|March 27, 2014
"East asian paradox": challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndromeYoung-Hoon Jeong
The New England Journal of Medicine|October 4, 2013
Clopidogrel with aspirin in minor stroke or transient ischemic attackYoung-Hoon Jeong
Korean Circulation Journal|April 7, 2022
Unguided De-Escalation Strategy From Potent P2Y<sub>12</sub> Inhibitors in Patients Presented With ACS: When, Whom and How?Jin Sup Park, Young-Hoon Jeong
JACC. Asia|January 9, 2023
Thrombosis and Anticoagulation in East Asian Patients With COVID-19: Another Phenotype of "East Asian Paradox"You-Jeong Ki, Young-Hoon Jeong
Journal of the American Heart Association|May 28, 2015
Platelet function tests: why they fail to guide personalized antithrombotic medicationDiana A Gorog, Young-Hoon Jeong
Thrombosis and Haemostasis|March 31, 2025
Factor XI Measurement in Acute Coronary SyndromeDiana A Gorog, Young-Hoon Jeong
Korean Circulation Journal|December 19, 2023
Type 2 Myocardial Infarction: Another Hidden Cause of Mortality During the COVID-19 PandemicEun Jeong Cho, Kyeongmin Byeon, Young-Hoon Jeong
JACC. Asia|November 6, 2025
Ethnicity, P2Y<sub>12</sub> Inhibitor Potency, and Bleeding: Revisiting the "East Asian Paradox"Phil Iver Guevarra, Udaya Tantry, Young-Hoon Jeong
JAMA|March 2, 2021
Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous InterventionHyun Kuk Kim, Jacek Kubica, Young-Hoon Jeong
JAMA|June 23, 2011
Standard- vs high-dose clopidogrel after percutaneous coronary interventionYoung-Hoon Jeong, Yongwhi Park, In-Suk Kim
Pageof 27